If sensor glucose values are predicted to drop or rise, the algorithm can automatically reduce or increase basal insulin infusion to totally suspend in case of predicted hypoglycemia (<70 mg/dL) or to release correction boluses in case of hyperglycemia (>180 mg/dL). The gene discussed is INS; the disease is Hypoglycemia.